CN105288215A - High-activity dendrobium officinale kimura et migo freeze-drying powder buccal tablets and preparation process thereof - Google Patents

High-activity dendrobium officinale kimura et migo freeze-drying powder buccal tablets and preparation process thereof Download PDF

Info

Publication number
CN105288215A
CN105288215A CN201510794478.0A CN201510794478A CN105288215A CN 105288215 A CN105288215 A CN 105288215A CN 201510794478 A CN201510794478 A CN 201510794478A CN 105288215 A CN105288215 A CN 105288215A
Authority
CN
China
Prior art keywords
parts
herba dendrobii
lyophilized powder
buccal tablet
high activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510794478.0A
Other languages
Chinese (zh)
Inventor
周伟刚
周俊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhui Qianfang Biological Technology Co Ltd
Original Assignee
Anhui Qianfang Biological Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhui Qianfang Biological Technology Co Ltd filed Critical Anhui Qianfang Biological Technology Co Ltd
Priority to CN201510794478.0A priority Critical patent/CN105288215A/en
Publication of CN105288215A publication Critical patent/CN105288215A/en
Pending legal-status Critical Current

Links

Abstract

The present invention discloses high-activity dendrobium officinale kimura et migo freeze-drying powder buccal tablets and a preparation process thereof, and relates to the technical field of traditional Chinese medicines or health products, wherein the buccal tablets are prepared from the following raw materials: dendrobium officinale kimura et migo freeze-drying powder, xylitol, a Chinese wolfberry extract, mannitol, isomaltitol, sodium carboxymethyl starch, and magnesium stearate. According to the present invention, the advanced nanometer crushing technology is used to replace the traditional organic extraction technology so as to avoid the risk of the organic extractant residue in the buccal tablets; the dendrobium officinale kimura et migo freeze-drying powder is prepared into the ultra-micro powder, such that the release of most of the active ingredients in the dendrobium officinale kimura et migo is easily achieved; and the product has characteristics of easy taking, no requirement of water during taking, and no coating component, and can be directly absorbed through oral mucosa, such that the nutrient loss produced during the absorption through the human body gastrointestinal, liver and other organs is avoided, and the absorption utilization rate of the nutrients in the dendrobium officinale kimura et migo is improved.

Description

A kind of high activity Herba Dendrobii lyophilized powder buccal tablet and preparation technology thereof
Technical field
The present invention relates to Chinese medicine or health product technology field, be specifically related to a kind of high activity Herba Dendrobii lyophilized powder buccal tablet and preparation technology thereof.
Background technology
In recent years, along with development and the growth in the living standard of science and technology, the average life of compatriots constantly extends, aging is stepped into gradually in many cities, in order to improve the quality of living, strengthen life effect, the health product of reasonable employment illness prevention and fitness oneself become the conscious requirement of one of people gradually, the research and development in this field also more and more comes into one's own.
Herba Dendrobii, one of orchid, as valuable medical material, is mainly distributed in Tropical Asian and subtropical zone, Australia and Pacific Islands.In China, major part is distributed in the ground such as southwest, south China, Taiwan.As medical material or food materials, its source mostly is the fresh or dry stem of the orchid family herbaceos perennial Dendrobium nobile and Herba Dendrobii; Herba Dendrobii, as the valuable ingredients of traditional Chinese medicine, has reinforcing stomach reg fluid, drives solution deficiency-heat, the curative effects such as beneficial smart reinforcing YIN-essence.Containing a large amount of dendrobines and polysaccharide slime formers matter in Herba Dendrobii; Wherein, dendrobine has certain pain relieving antipyretic effect, similar to phenacetin but more weak; Dendrobium polysaccharide energy enhancing human body immunity function, and there is anti-tumor activity.But adopt conventional decocting method, the effective ingredient not easily stripping of Herba Dendrobii, causes bioavailability low.Application number is the patent of invention of 200910095107.8, provides a kind of dendrobium tea, is made up of the component of following masses part: Herba Dendrobii 3 ~ 7 parts, Herb Gynostemmae Pentaphylli 2 ~ 3 parts, kidney tea 3 ~ 7 parts, Folium Camelliae sinensis 3 ~ 7 parts, 3 ~ 5 parts, sugar.When dendrobium tea uses, with water as solvent, make bioavailability low.Because the dendrobine in Herba Dendrobii, water insoluble as alkaloid, only can be dissolved in the organic solvents such as ethanol, chloroform, ether.For solving the low problem of dissolution, traditional Herba Dendrobii needs to decoct 4-5 hour, and guarantee effective ingredient is used appropriately.Application number is the patent of invention of 201210473859.5, disclose a kind of dendrobium officinale granula, it is primarily of Herba Dendrobii, Poria, Radix Ginseng, Fructus Lycii, Rhizoma Dioscoreae and Semen Coicis composition, wherein, the weight proportion of described Herba Dendrobii, Poria, Radix Ginseng, Fructus Lycii, Rhizoma Dioscoreae, Semen Coicis is: 15 ~ 28:30 ~ 42:7 ~ 18:3 ~ 13:15 ~ 28:15 ~ 28.But this dosage form can not directly act on oral mucosa, and be difficult to the effect realizing Herba Dendrobii cleaning throat and moistening larynx.
Buccal tablet refers to be contained in the compressed tablet slowly dissolved in oral cavity, except the basic demand meeting tablet (as dissolution), also must possess tempting color, the mouthfeel had to make user.Tradition is prepared in the technique of buccal tablet, often adopts organic extraction techniques, can remain organic extractant, not only affect the mouthfeel of buccal tablet, nor be beneficial to healthy in buccal tablet obtained like this.
Summary of the invention
(1) technical problem solved
For the deficiencies in the prior art, the invention provides a kind of high activity Herba Dendrobii lyophilized powder buccal tablet and preparation technology thereof.High activity Herba Dendrobii lyophilized powder buccal tablet of the present invention uses advanced nano-pulverization technology to instead of traditional organic extraction techniques, avoid the risk that in buccal tablet, organic extractant is residual, Herba Dendrobii lyophilized powder is made the release that superfine powder is very beneficial for most active component in Herba Dendrobii; This product is easily oral simultaneously, without the need to water when taking, and without coating constituents, directly can be absorbed by oral mucosa, avoid nutritional labeling by the loss produced during the absorbed organ such as human intestines and stomach and liver, improve the absorption rate of Herba Dendrobii Middle nutrition composition.
(2) technical scheme
For realizing above object, the present invention is achieved by the following technical programs:
A kind of high activity Herba Dendrobii lyophilized powder buccal tablet, is made up of the raw material of following weight portion: Herba Dendrobii lyophilized powder 80-120 part, Xylitol 60-80 part, wolfberry fruit extract 35-60 part, mannitol 20-35 part, hydroxyl isomaltulose 15-25 part, carboxymethyl starch sodium 5-16 part, magnesium stearate 20-30 part.
Preferably, described high activity Herba Dendrobii lyophilized powder buccal tablet is made up of the raw material of following weight portion: Herba Dendrobii lyophilized powder 90-110 part, Xylitol 65-70 part, wolfberry fruit extract 45-56 part, mannitol 26-30 part, hydroxyl isomaltulose 18-22 part, carboxymethyl starch sodium 8-12 part, magnesium stearate 24-28 part.
Preferably, described high activity Herba Dendrobii lyophilized powder buccal tablet is made up of the raw material of following weight portion: Herba Dendrobii lyophilized powder 100 parts, Xylitol 68 parts, wolfberry fruit extract 50 parts, 28 parts, mannitol, hydroxyl isomaltulose 20 parts, carboxymethyl starch sodium 10 parts, magnesium stearate 26 parts.
Preferably, described high activity Herba Dendrobii lyophilized powder buccal tablet is made up of the raw material of following weight portion: Herba Dendrobii lyophilized powder 100 parts, Xylitol 68 parts, wolfberry fruit extract 50 parts, 28 parts, mannitol, hydroxyl isomaltulose 20 parts, carboxymethyl starch sodium 10 parts, magnesium stearate 26 parts.
A preparation technology for high activity Herba Dendrobii lyophilized powder buccal tablet, comprises the following steps:
(1) get the raw materials ready: select the measured raw material of matter, take raw material according to weight portion, for subsequent use;
(2) batch mixing: Herba Dendrobii lyophilized powder nano grinder is milled to below 100nm, obtains dendrobe ultrafine powder, subsequently dendrobe ultrafine powder, Xylitol, wolfberry fruit extract and carboxymethyl starch sodium are fully mixed 20min, crosses 80 mesh sieves, obtains compound;
(3) granulate: step (2) gained compound is dropped in Multidimensionblender, then adds distilled water as wetting agent, stir, afterwards sufficient for mixing soft material is dropped into oscillating granulator 14 order nylon screens and granulate;
(4) dry: step (3) gained wet granular is placed in hot air circulation drying oven, and dry 1-2 hour at 55-65 DEG C, makes it water content and be down to 2%-4%, obtains dry granule;
(5) perfuming: described mannitol is fully mixed with dry granule;
(6) tabletting: after step (5), add described hydroxyl isomaltulose and magnesium stearate, carry out tabletting after mix homogeneously, packs and obtains Herba Dendrobii lyophilized powder buccal tablet under purification condition.
Preferably, step (4) described baking temperature is 60 DEG C.
(3) beneficial effect
The invention provides a kind of high activity Herba Dendrobii lyophilized powder buccal tablet and preparation technology thereof, described high activity Herba Dendrobii lyophilized powder buccal tablet uses advanced nano-pulverization technology to instead of traditional organic extraction techniques, avoid the risk that in buccal tablet, organic extractant is residual, Herba Dendrobii lyophilized powder is made the release that superfine powder is very beneficial for most active component in Herba Dendrobii; This product is easily oral simultaneously, without the need to water when taking, and without coating constituents, directly can be absorbed by oral mucosa, avoid nutritional labeling by the loss produced during the absorbed organ such as human intestines and stomach and liver, improve the absorption rate of Herba Dendrobii Middle nutrition composition; In addition, the mannitol correctives added, makes the buccal tablet mouthfeel that obtains better.
Detailed description of the invention
For making the object of the embodiment of the present invention, technical scheme and advantage clearly, below in conjunction with the embodiment of the present invention, the technical scheme in the embodiment of the present invention is clearly and completely described, obviously, described embodiment is the present invention's part embodiment, instead of whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art, not making the every other embodiment obtained under creative work prerequisite, belong to the scope of protection of the invention.
Embodiment 1:
The present embodiment high activity Herba Dendrobii lyophilized powder buccal tablet, is made up of the raw material of following weight portion: Herba Dendrobii lyophilized powder 90 parts, Xylitol 65 parts, wolfberry fruit extract 45 parts, 26 parts, mannitol, hydroxyl isomaltulose 18 parts, carboxymethyl starch sodium 8 parts, magnesium stearate 24 parts.
Preparation method, comprises the following steps:
(1) get the raw materials ready: select the measured raw material of matter, take raw material according to weight portion, for subsequent use;
(2) batch mixing: Herba Dendrobii lyophilized powder nano grinder is milled to below 100nm, obtains dendrobe ultrafine powder, subsequently dendrobe ultrafine powder, Xylitol, wolfberry fruit extract and carboxymethyl starch sodium are fully mixed 20min, crosses 80 mesh sieves, obtains compound;
(3) granulate: step (2) gained compound is dropped in Multidimensionblender, then adds distilled water as wetting agent, stir, afterwards sufficient for mixing soft material is dropped into oscillating granulator 14 order nylon screens and granulate;
(4) dry: step (3) gained wet granular is placed in hot air circulation drying oven, and dry 1-2 hour at 60 DEG C, makes it water content and be down to 2%-4%, obtains dry granule;
(5) perfuming: described mannitol is fully mixed with dry granule;
(6) tabletting: after step (5), add described hydroxyl isomaltulose and magnesium stearate, carry out tabletting after mix homogeneously, packs and obtains Herba Dendrobii lyophilized powder buccal tablet under purification condition.
Embodiment 2:
The present embodiment high activity Herba Dendrobii lyophilized powder buccal tablet, is made up of the raw material of following weight portion: Herba Dendrobii lyophilized powder 100 parts, Xylitol 68 parts, wolfberry fruit extract 50 parts, 28 parts, mannitol, hydroxyl isomaltulose 20 parts, carboxymethyl starch sodium 10 parts, magnesium stearate 26 parts.
According to the present embodiment parts by weight of raw materials, preparation method is with embodiment 1.
Embodiment 3:
The present embodiment high activity Herba Dendrobii lyophilized powder buccal tablet, is made up of the raw material of following weight portion: Herba Dendrobii lyophilized powder 110 parts, Xylitol 70 parts, wolfberry fruit extract 56 parts, 30 parts, mannitol, hydroxyl isomaltulose 22 parts, carboxymethyl starch sodium 12 parts, magnesium stearate 28 parts.
According to the present embodiment parts by weight of raw materials, preparation method is with embodiment 1.
Embodiment 4:
The present embodiment high activity Herba Dendrobii lyophilized powder buccal tablet, is made up of the raw material of following weight portion: Herba Dendrobii lyophilized powder 80 parts, Xylitol 60 parts, wolfberry fruit extract 35 parts, 20 parts, mannitol, hydroxyl isomaltulose 15 parts, carboxymethyl starch sodium 5 parts, magnesium stearate 20 parts.
According to the present embodiment parts by weight of raw materials, preparation method is with embodiment 1.
Embodiment 5:
The present embodiment high activity Herba Dendrobii lyophilized powder buccal tablet, is made up of the raw material of following weight portion: Herba Dendrobii lyophilized powder 120 parts, Xylitol 80 parts, wolfberry fruit extract 60 parts, 35 parts, mannitol, hydroxyl isomaltulose 25 parts, carboxymethyl starch sodium 16 parts, magnesium stearate 30 parts.
According to the present embodiment parts by weight of raw materials, preparation method is with embodiment 1.
Embodiment 6:
The present embodiment high activity Herba Dendrobii lyophilized powder buccal tablet, is made up of the raw material of following weight portion: Herba Dendrobii lyophilized powder 100 parts, Xylitol 68 parts, wolfberry fruit extract 50 parts, 28 parts, mannitol, hydroxyl isomaltulose 20 parts, carboxymethyl starch sodium 10 parts, magnesium stearate 26 parts.
According to the present embodiment parts by weight of raw materials, preparation method is with embodiment 1.
Clinical experiment
Embodiment 1 buccal tablet obtained respectively by above-described embodiment 1,2,3,4,5,6, embodiment 2 buccal tablet, embodiment 3 buccal tablet, embodiment 4 buccal tablet, embodiment 5 buccal tablet and embodiment 6 buccal tablet, taking convenience mouthfeel is good, after testing not to the composition that human body has side effects.Take through hundred people, take for each person every day 3 (1g/ sheets), prove diabetes-alleviating, improve the intestines and stomach, raising mental status has remarkable result.
Result of use is as shown in the table:
As can be seen from upper table data, take buccal tablet 1 of the present invention, buccal tablet 2 and buccal tablet 3 pairs of type Ⅱdiabetes mellitus, the incongruous tired lassitude person of the intestines and stomach has obvious curative effects, and the effect of buccal tablet 2 is best.
It should be noted that, in this article, the such as relational terms of first and second grades and so on is only used for an entity or operation to separate with another entity or operating space, and not necessarily requires or imply the relation that there is any this reality between these entities or operation or sequentially.And, term " comprises ", " comprising " or its any other variant are intended to contain comprising of nonexcludability, thus make to comprise the process of a series of key element, method, article or equipment and not only comprise those key elements, but also comprise other key elements clearly do not listed, or also comprise by the intrinsic key element of this process, method, article or equipment.When not more restrictions, the key element limited by statement " comprising ... ", and be not precluded within process, method, article or the equipment comprising described key element and also there is other identical element.
Above embodiment is only in order to illustrate technical scheme of the present invention, be not intended to limit, although with reference to previous embodiment to invention has been detailed description, those of ordinary skill in the art is to be understood that: it still can be modified to the technical scheme described in foregoing embodiments, or carries out equivalent replacement to wherein portion of techniques feature; And these amendments or replacement, do not make the essence of appropriate technical solution depart from the spirit and scope of various embodiments of the present invention technical scheme.

Claims (6)

1. a high activity Herba Dendrobii lyophilized powder buccal tablet, it is characterized in that, described high activity Herba Dendrobii lyophilized powder buccal tablet is made up of the raw material of following weight portion: Herba Dendrobii lyophilized powder 80-120 part, Xylitol 60-80 part, wolfberry fruit extract 35-60 part, mannitol 20-35 part, hydroxyl isomaltulose 15-25 part, carboxymethyl starch sodium 5-16 part, magnesium stearate 20-30 part.
2. high activity Herba Dendrobii lyophilized powder buccal tablet according to claim 1, it is characterized in that, described high activity Herba Dendrobii lyophilized powder buccal tablet is made up of the raw material of following weight portion: Herba Dendrobii lyophilized powder 90-110 part, Xylitol 65-70 part, wolfberry fruit extract 45-56 part, mannitol 26-30 part, hydroxyl isomaltulose 18-22 part, carboxymethyl starch sodium 8-12 part, magnesium stearate 24-28 part.
3. high activity Herba Dendrobii lyophilized powder buccal tablet according to claim 1, it is characterized in that, described high activity Herba Dendrobii lyophilized powder buccal tablet is made up of the raw material of following weight portion: Herba Dendrobii lyophilized powder 100 parts, Xylitol 68 parts, wolfberry fruit extract 50 parts, 28 parts, mannitol, hydroxyl isomaltulose 20 parts, carboxymethyl starch sodium 10 parts, magnesium stearate 26 parts.
4. high activity Herba Dendrobii lyophilized powder buccal tablet according to claim 1, it is characterized in that, described high activity Herba Dendrobii lyophilized powder buccal tablet is made up of the raw material of following weight portion: Herba Dendrobii lyophilized powder 100 parts, Xylitol 75 parts, wolfberry fruit extract 40 parts, 32 parts, mannitol, hydroxyl isomaltulose 23 parts, carboxymethyl starch sodium 10 parts, magnesium stearate 22 parts.
5. a preparation technology for the high activity Herba Dendrobii lyophilized powder buccal tablet as described in as arbitrary in claim 1-4, is characterized in that, comprise the following steps:
(1) get the raw materials ready: select the measured raw material of matter, take raw material according to weight portion, for subsequent use;
(2) batch mixing: Herba Dendrobii lyophilized powder nano grinder is milled to below 100nm, obtain dendrobe ultrafine powder, subsequently dendrobe ultrafine powder, Xylitol, wolfberry fruit extract and carboxymethyl starch sodium are fully mixed 18-25min, cross 80-100 mesh sieve, obtain compound;
(3) granulate: step (2) gained compound is dropped in Multidimensionblender, then adds distilled water as wetting agent, stir, afterwards sufficient for mixing soft material is dropped into oscillating granulator 14 order nylon screens and granulate;
(4) dry: step (3) gained wet granular is placed in hot air circulation drying oven, and dry 1-2 hour at 55-65 DEG C, makes it water content and be down to 2%-4%, obtains dry granule;
(5) perfuming: described mannitol is fully mixed with dry granule;
(6) tabletting: after step (5), add described hydroxyl isomaltulose and magnesium stearate, carry out tabletting after mix homogeneously, packs and obtains Herba Dendrobii lyophilized powder buccal tablet under purification condition.
6. the preparation technology of high activity Herba Dendrobii lyophilized powder buccal tablet according to claim 5, it is characterized in that, step (4) described baking temperature is 60 DEG C.
CN201510794478.0A 2015-11-17 2015-11-17 High-activity dendrobium officinale kimura et migo freeze-drying powder buccal tablets and preparation process thereof Pending CN105288215A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510794478.0A CN105288215A (en) 2015-11-17 2015-11-17 High-activity dendrobium officinale kimura et migo freeze-drying powder buccal tablets and preparation process thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510794478.0A CN105288215A (en) 2015-11-17 2015-11-17 High-activity dendrobium officinale kimura et migo freeze-drying powder buccal tablets and preparation process thereof

Publications (1)

Publication Number Publication Date
CN105288215A true CN105288215A (en) 2016-02-03

Family

ID=55186493

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510794478.0A Pending CN105288215A (en) 2015-11-17 2015-11-17 High-activity dendrobium officinale kimura et migo freeze-drying powder buccal tablets and preparation process thereof

Country Status (1)

Country Link
CN (1) CN105288215A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105708907A (en) * 2016-02-18 2016-06-29 刘起宏 Traditional Chinese medicine tea substitute beverage for treating hypertension and hyperglycemia and preparation method thereof
CN105726986A (en) * 2016-03-10 2016-07-06 浙江万寿康药业有限公司 Production process of Dendrobium officinale fine powder
CN106473143A (en) * 2016-10-19 2017-03-08 南京希元生物医药科技有限公司 A kind of Herba Dendrobii lyophilized powder buccal tablet
CN106938008A (en) * 2017-03-31 2017-07-11 泸州德高生物科技有限公司 A kind of processing technology of the oral freeze-dried powder of the ecological bletilla striata
CN108991331A (en) * 2018-06-27 2018-12-14 广西驰胜农业科技有限公司 A kind of dendrobium candidum medicine materical crude slice and its preparation method and application
CN109528933A (en) * 2018-12-29 2019-03-29 中南民族大学 A kind of application of the compound formulation including tomorrow leaf in prevention or medicaments for treating sexual disorder
CN116251154A (en) * 2023-04-04 2023-06-13 六安康顺堂石斛有限公司 Dendrobium nobile freeze-dried powder processing method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101658639A (en) * 2009-08-26 2010-03-03 浙江森宇实业有限公司 Dendrobium candidum polysaccharide buccal tablet and preparing method thereof
CN102406842A (en) * 2011-11-30 2012-04-11 中山市中智药业集团有限公司 Traditional Chinese medicine dendrobium candidum buccal tablets
CN102415568A (en) * 2011-12-13 2012-04-18 常熟雷允上制药有限公司 Health food for improving immunity and preparation method thereof
CN103285242A (en) * 2013-05-23 2013-09-11 重庆市中药研究院 Dendrobium buccal tablets and preparation method for same
CN104758257A (en) * 2015-04-02 2015-07-08 贵州同威生物科技有限公司 Fresh dendrobium officinale freeze-dried powder and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101658639A (en) * 2009-08-26 2010-03-03 浙江森宇实业有限公司 Dendrobium candidum polysaccharide buccal tablet and preparing method thereof
CN102406842A (en) * 2011-11-30 2012-04-11 中山市中智药业集团有限公司 Traditional Chinese medicine dendrobium candidum buccal tablets
CN102415568A (en) * 2011-12-13 2012-04-18 常熟雷允上制药有限公司 Health food for improving immunity and preparation method thereof
CN103285242A (en) * 2013-05-23 2013-09-11 重庆市中药研究院 Dendrobium buccal tablets and preparation method for same
CN104758257A (en) * 2015-04-02 2015-07-08 贵州同威生物科技有限公司 Fresh dendrobium officinale freeze-dried powder and preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
崔今淑等: "《食疗美容秘笈》", 30 April 2011, 延边大学出版社 *
蔡光先等: "铁皮石斛古代与现代的应用概况", 《湖南中医药大学学报》 *
赵静等: "《中药饮片临床应用与辨析》", 31 October 2015, 中国中医药出版社 *
郑建仙等: "《功能性食品甜味剂》", 30 November 1997, 中国轻工业出版社 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105708907A (en) * 2016-02-18 2016-06-29 刘起宏 Traditional Chinese medicine tea substitute beverage for treating hypertension and hyperglycemia and preparation method thereof
CN105726986A (en) * 2016-03-10 2016-07-06 浙江万寿康药业有限公司 Production process of Dendrobium officinale fine powder
CN106473143A (en) * 2016-10-19 2017-03-08 南京希元生物医药科技有限公司 A kind of Herba Dendrobii lyophilized powder buccal tablet
CN106938008A (en) * 2017-03-31 2017-07-11 泸州德高生物科技有限公司 A kind of processing technology of the oral freeze-dried powder of the ecological bletilla striata
CN108991331A (en) * 2018-06-27 2018-12-14 广西驰胜农业科技有限公司 A kind of dendrobium candidum medicine materical crude slice and its preparation method and application
CN109528933A (en) * 2018-12-29 2019-03-29 中南民族大学 A kind of application of the compound formulation including tomorrow leaf in prevention or medicaments for treating sexual disorder
CN116251154A (en) * 2023-04-04 2023-06-13 六安康顺堂石斛有限公司 Dendrobium nobile freeze-dried powder processing method

Similar Documents

Publication Publication Date Title
CN105288215A (en) High-activity dendrobium officinale kimura et migo freeze-drying powder buccal tablets and preparation process thereof
CN103285242B (en) Herba Dendrobii buccal tablet and preparation method thereof
CN101518580B (en) Pharmaceutical composition for clearing heat and releasing toxin as well as preparation method and application thereof
CN103263588A (en) Compound buccal tablet containing dendrobium nobile and honeysuckle and preparation method thereof
CN107495367A (en) A kind of food, health products or pharmaceutical composition for improving hypoxia-bearing capability and its production and use
CN112021555A (en) Ganoderma lucidum spore powder tablet and preparation method thereof
CN102784219B (en) Compound pure Chinese medicine composition for treating bovine ephemeral fever and preparation method of same
CN104784505A (en) Dendrobium officinale healthcare product with auxiliary blood glucose reducing function and preparation method thereof
CN102085327A (en) Ginseng, tuckahoe and largehead atractylodes rhizome capsules
CN103155985A (en) Rhizoma polygonati nutrition powder and preparation method thereof
CN102961584B (en) Traditional Chinese medicine composition capable of relieving fatigue, as well as preparation method and application thereof
CN102600358A (en) Traditional Chinese laxative medicine and product thereof
CN102145144A (en) Traditional Chinese medicine preparation for treatment of asthma
CN104547767A (en) Processing method of medicinal fermented mass particles
CN102793839A (en) Taste-modifying Chinese medicinal preparation and preparation method thereof
CN102178754A (en) Formula for nerve-calming effervescent tablets and preparation method thereof
CN104127823A (en) Traditional Chinese medicine composition for treating infantile malnutrition and anorexia and preparation thereof
CN102600325B (en) Compound propolis composition for treatment of porcine contagious pleuropneumonia and preparation method thereof
CN109010514A (en) Composition, health care product and the preparation method of altitude sickness prevention
CN108143833A (en) A kind of preparation method of licorice piece
CN103599343A (en) Pharmaceutical composition for treating diabetes, and preparation method and application thereof
CN103301306A (en) Korla bergamot pear lozenge for relieving cough and asthma
CN105250429A (en) Medicine composition for treating allergy and preparation method and application of medicine composition
CN102188606A (en) Formula for yin nourishing and lung moistening effervescent tables and preparation method thereof
CN105232923A (en) Foot bath medicine for treating specific endowment constitution and preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160203